Uncategorized Archives - Geneseeq Technology Inc. | A Precision Oncology Company

November 15, 2022

Geneseeq Publishes Promising Early Lung Cancer Detection Results in AJRCCM

August 3, 2022

GENESEEQ AND COLLABORATORS SHARE NEW FINDINGS AT WORLD CONFERENCE ON LUNG CANCER 2022

July 19, 2022

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab

April 5, 2022

Geneseeq Presents 9 Posters at AACR 2022

November 22, 2021

Geneseeq announces new publication utilizing ultradeep sequencing technology Automated TTriple Groom sequencing (ATG-seq) to monitor minimal residual disease in postoperative non-small cell lung cancer

November 11, 2021

Geneseeq Forms Lung Cancer Strategic Partnerships with Takeda and AstraZeneca on the Same Day

September 8, 2021

Geneseeq Presents ctDNA Early Lung Cancer Detection Data at WCLC

June 17, 2021

Geneseeq Joins Integrated DNA Technologies (IDT) Align Program

March 19, 2021

Lung cancer genomic study reveals timing and origins of local and distant metastases and highlights the importance of early cancer detection

June 2, 2020

Geneseeq to showcase novel translational research at the 2020 AACR Virtual Annual Meeting II